药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dioxaphetyl butyrate
Sarecycline
The serum concentration of Ertugliflozin can be increased when it is combined with Sarecycline.
Dioxaphetyl butyrate
Voxilaprevir
The serum concentration of Ertugliflozin can be increased when it is combined with Voxilaprevir.
Dioxaphetyl butyrate
Valspodar
The serum concentration of Ertugliflozin can be increased when it is combined with Valspodar.
Dioxaphetyl butyrate
Neratinib
The serum concentration of Ertugliflozin can be increased when it is combined with Neratinib.
Dioxaphetyl butyrate
Brefeldin A
The serum concentration of Ertugliflozin can be increased when it is combined with Brefeldin A.
Dioxaphetyl butyrate
Pralsetinib
Pralsetinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Ripretinib
Ripretinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Abemaciclib
Abemaciclib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Fedratinib
Fedratinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Nabiximols
Nabiximols may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Medical Cannabis
Medical Cannabis may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Brigatinib
Brigatinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Gilteritinib
Gilteritinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Fostamatinib
Fostamatinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Avatrombopag
Avatrombopag may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Glasdegib
Glasdegib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Dacomitinib
Dacomitinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Dioxaphetyl butyrate
Apalutamide
The serum concentration of Ertugliflozin can be decreased when it is combined with Apalutamide.
Dioxaphetyl butyrate
Gastric inhibitory polypeptide
The therapeutic efficacy of Gastric inhibitory polypeptide can be increased when used in combination with Ertugliflozin.
Dioxaphetyl butyrate
Tirzepatide
The therapeutic efficacy of Tirzepatide can be increased when used in combination with Ertugliflozin.